SEC Form 4 · accession 0001179110-15-004210
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Hagen
Officer — SVP Manufacturing & Pharmaceut
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | A | 7,530 | $17.05 | A | 32,621 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $17.05 | Mar 2, 2015 | A | 16,280 | A | — | Mar 2, 2025 | Common Stock | 16,280 | 16,280 | D |
Explanation of responses
- F1Option that is exercisable as to 1/4th of the shares annually on the anniversary date of the grant for each of the next four years.